Latest Announcements

Investor Announcement

Prana AGM investor webcast details

Prana Biotechnology will host a webcast at its Annual General Meeting on Thursday 17th November 2016 at 9.30am AEDT.

 

Investor Announcement, Huntington's Disease

Prana provides regulatory update for PBT2 for the treatment of Huntington disease

Prana today announced that is has received further advice from the US Food and Drug Administration (FDA) on the steps necessary to remove the Partial Clinical Hold (PCH) on PBT2, including the requirement to undertake further non-clinical studies.

Multimedia

Movement disorders expert Professor Ira Shoulson joins Prana Biotechnology's Board of Directors

Email Newsletter

Receive regular updates from Prana Biotechnology by entering your details below and clicking "Subscribe"